Did They Pay?

Tag: Prior Authorization

  • Medicare Advantage Prior Authorization Denials: What the 2024 Numbers Really Show

    Medicare Advantage insurers denied millions of prior authorization requests in 2024, but a denial count alone cannot tell whether a particular patient was treated fairly. The important questions are what was requested, why coverage was refused, whether the decision was appealed, and what happened afterward. Public statistics identify patterns; clinical records test individual decisions.

    What do the national numbers show?

    KFF’s January 2026 analysis of federal data found nearly 53 million Medicare Advantage prior authorization determinations in 2024. Insurers denied about 4.1 million, or 7.7%, in whole or in part. These are authorization requests, not necessarily unique patients. One patient may need approval for several services, and a denied request does not automatically mean care was never provided.

    Only 11.5% of denied requests were appealed. Among appealed denials, 80.7% were overturned. The high reversal rate deserves scrutiny, but it does not mean 80.7% of all initial denials were improper: the appealed cases are a selected subset, and some approvals follow submission of additional records. It does demonstrate why an initial denial should not automatically end the process.

    What the statistics cannot prove

    Insurers’ authorization rates depend partly on which services require approval, the clinical needs of enrollees, and how requests are recorded. A parent insurance company may operate several Medicare Advantage contracts, and its individual plans may have different rules. An insurer-wide rate cannot establish the correctness of a particular plan’s decision.

    A meaningful investigation identifies the plan contract, requested service, clinical criteria, denial rationale, records submitted, appeal outcome, and actual treatment delay. Comparing unlike service categories can mislead. Researchers should also distinguish an initial request denied for missing information from a determination that a complete request failed medical-necessity criteria.

    How to examine an individual denial

    Patients should request the written determination, service codes, specific clinical criterion, and any explanation of missing records. Providers should compare the decision with the clinician’s order, examination findings, diagnostic tests, treatment history, and plan criteria effective on the decision date.

    Build a dated record of submission, confirmation, information requests, initial decision, peer-to-peer discussion, appeal, and revised determination. Record whether treatment occurred and when. Do not label a medical complication as caused by the insurer without competent evidence. An accurate chronology is more useful than a broad accusation.

    What changed under federal rules in 2026?

    CMS’s 2024 interoperability and prior authorization final rule established, beginning in 2026, seven-calendar-day limits for standard medical-service authorization decisions and 72-hour limits for expedited decisions for certain impacted payers, including Medicare Advantage organizations. Decisions must be sooner when medical circumstances require it. The rules exclude drugs and do not impose the same new timeline on every commercial plan.

    CMS also requires impacted payers to provide specific reasons for prior authorization denials. Do not apply these 2026 provisions retroactively to 2024 cases. For current requests, verify the precise coverage program and service before asserting a legal deadline.

    A practical investigation checklist

    Identify the plan and requested service; obtain the dated determination and actual criteria; preserve submission receipts; compare clinical documentation with the stated reason; verify the appeal route and deadline; and record the ultimate outcome. Keep patient-facing explanations separate from internal coding shorthand.

    A useful appeal opening is: ‘The plan denied [service] on [date] because [reason]. Enclosed records address that criterion by documenting [facts]. Please identify any remaining requirement that is not met and provide a written reconsideration.’ The treating clinician should review clinical assertions before submission.

    Frequently asked questions

    Does an 80.7% reversal rate mean most denials are illegal? No. It measures reversals among appealed denials, not all denials, and says nothing definitive about the legal merits of an individual decision.

    Can a provider appeal? Often, with the appropriate authorization and plan-specific procedures. For help preparing a focused appeal, see our evidence-based appeals guide.

    Sources and further reading

    KFF: Medicare Advantage prior authorization data

    CMS: Improving Prior Authorization Processes

    CMS: Final Rule announcement

  • What Should You Do When Prior Authorization Delays Medically Necessary Treatment?

    A prior authorization delay calls for two parallel responses: protect the patient’s clinical needs and document exactly where the insurer’s review stands. Ask the treating clinician whether the situation warrants urgent handling, confirm the payer received a complete request, obtain a tracking number and written reason for any denial, and preserve the appeal deadline. Do not assume a pending request is an actual denial.

    Why is prior authorization different from a claim denial?

    Prior authorization generally asks a payer to approve an item or service before it is delivered. A claim denial typically occurs after billing. That distinction changes which documents and deadlines apply. A service can be medically appropriate without meeting a plan’s coverage terms; conversely, an administrative denial does not establish that care is medically unnecessary. Patients should ask what decision the insurer has actually made: incomplete submission, pending clinical review, noncoverage, or an adverse determination.

    What should the patient and clinic verify first?

    Obtain the service description, requested procedure code when available, ordering clinician, submitting office, payer, member identification, submission date, and tracking number. Ask whether clinical notes, test results, and a letter explaining medical necessity were attached. Confirm whether the request was sent to the right benefits administrator and whether it is being evaluated under medical or pharmacy benefits. If the payer says information is missing, request a specific written list rather than guessing. A clinic can then resubmit only the missing items while preserving a record of the original request.

    When is an expedited review appropriate?

    Clinical urgency is not determined by how frustrated a caller feels. Ask the treating clinician to explain whether delay could seriously jeopardize health or the ability to regain maximum function, using the plan’s actual expedited-review standard. The clinician should document the clinical risk and communicate it through the designated urgent channel. For affected non-drug requests under the CMS 2024 prior authorization rule, certain Medicare Advantage, Medicaid, and CHIP payers face decision timeframes of 72 hours for expedited requests and seven calendar days for standard requests beginning in 2026; payer-specific exceptions and other rules matter. The rule does not make every commercial plan or prescription drug request subject to those same clocks.

    A documentation checklist that works for both sides

    Keep a dated timeline: medical recommendation, submission, receipt confirmation, requests for more information, each phone call, decision, and any postponed appointment. Record the representative’s name, department, reference number, exact promise, and follow-up date. Patients should save appointment cancellation notices and actual out-of-pocket costs; clinics should retain portal receipts and transmission confirmations. Keep observed consequences separate from predictions about clinical harm. For a structured example, see our guide to documenting delayed care.

    How should a caller ask for accountability?

    Use a short, factual script: “Please confirm the date the complete request was received, its current status, the specific information still needed, the applicable decision deadline, and how to request an expedited review if my clinician determines it is appropriate. Please provide the determination and appeal instructions in writing.” If the first representative cannot identify the case, request the utilization-management unit or supervisor, but keep the conversation professional. The goal is a traceable answer, not a confrontation.

    What happens after a denial?

    Read the written notice and match the next step to the actual issue. An incomplete claim may need correction; an adverse medical-necessity determination may warrant an internal appeal with new clinical evidence; a coverage exclusion may require a different argument. Ask for the plan criterion or clinical guideline relied upon. If the decision is urgent, have the treating team check the appropriate expedited appeal or external-review pathway. The patient should not stop, delay, or change prescribed treatment solely because of a blog post; immediate clinical concerns belong with a licensed professional or emergency services.

    Frequently asked questions

    Does an authorization guarantee payment? No. Coverage, eligibility, coding, and contract terms may still affect the eventual claim.
    Can the doctor contact the insurer? Often, including through clinical review or peer-to-peer processes where available; ask the plan how those processes interact with formal appeal rights.
    Can I file a complaint? Depending on plan type, state insurance regulators or federal program administrators may help. A complaint may not replace a time-sensitive appeal.

    Official resources

    Read the CMS prior authorization final-rule fact sheet for covered payers, exclusions, and implementation dates; see HealthCare.gov’s overview of appeal rights for applicable private health plans. For Medicare Advantage, consult CMS guidance on organization determinations.

  • What Can Patients Do When a Step-Therapy Rule Blocks a Prescribed Medication?

    What Can Patients Do When a Step-Therapy Rule Blocks a Prescribed Medication The practical answer is to identify the exact rule or claim status, gather contemporaneous evidence, request a written explanation, and use the review pathway that applies to the specific plan. Patients and medical practices should keep a dated record of every handoff, because a documented sequence is more useful than repeated phone calls without reference numbers.

    What step therapy actually means

    Step therapy is a coverage rule that asks a patient to try a preferred treatment before the plan covers another one. It is not necessarily a clinical judgment that the prescribed medicine is inappropriate. A formulary rule may reflect clinical evidence, price negotiations, or both. The patient and prescriber should identify the exact plan requirement rather than assume that every rejection is a final denial.

    First determine whether this is a pharmacy transaction rejection or a formal coverage denial

    Ask the pharmacy for the rejection message and the precise medication, strength, quantity and days’ supply submitted. Ask the insurer or pharmacy benefit manager whether a prior authorization, formulary exception, step-therapy exception or corrected claim is needed. Request the policy criteria and any written adverse-benefit determination. A pharmacy’s on-screen rejection does not always start the same appeal clock as a formal plan denial.

    Build a clinically specific exception request

    The prescriber can explain the diagnosis, treatment goal, previously tried medications, dates, outcomes, adverse effects, contraindications, and why delaying the requested treatment could cause harm. Include relevant chart notes, laboratory findings and published clinical guidance where applicable. A statement that a preferred medication is merely inconvenient is less informative than an individualized explanation of why it is unsafe or unlikely to work.

    Use the right urgent pathway

    If delay could seriously jeopardize health or the ability to regain maximum function, ask the plan about expedited review. The applicable standard and deadline vary by plan type and whether the request concerns prospective treatment. Patients should seek timely clinical guidance rather than discontinue or substitute medicine without their treating professional’s advice.

    Track every handoff

    Record the date, representative, reference number, requested documents, recipient, submission channel and response deadline. Confirm that the prescriber and pharmacy have the same drug identifiers and that a successful approval is visible to the pharmacy. An approval for one dosage or formulation may not cover another.

    What if the exception is denied?

    Read the denial reason, identify the appeal route and submit the missing clinical evidence. Employer plans, Marketplace coverage, Medicare Part D and Medicaid can follow different rules. Ask for the relevant plan document and independent review rights. A state insurance department may assist with regulated plans; self-funded employer plans generally require a different regulatory path.

    Further reading and official guidance

    For a related practical discussion, see this Did They Pay? accountability guide. For official information, consult HealthCare.gov’s guide to appealing an insurer decision. Rules and deadlines depend on the coverage arrangement; check the current plan documents.

    Frequently asked questions

    Can my doctor simply write ‘medically necessary’?

    A medical-necessity statement helps, but specific history and the plan’s stated exception criteria usually make the request more useful.

    Does a pharmacy rejection mean my doctor was overruled?

    Not necessarily. It may indicate a missing authorization, an administrative mismatch or a coverage rule that has not yet received clinical review.

  • When an Insurance Delay Interrupts Care, What Should Patients Document First?

    When an insurance decision delays treatment, preserve both the insurance paperwork and a dated record of the effect on care. The most useful evidence connects a specific authorization, denial, or payment issue to an appointment, prescription, referral, or treatment decision. Ask clinicians to document medical concerns in their own professional judgment; do not exaggerate symptoms or assume every delay caused a medical injury.

    Record the decision and the planned care

    Begin with the written order or treatment recommendation, the date it was made, the planned appointment or treatment date, and the payer’s response. Record whether the issue was prior authorization, a coverage exclusion, a network restriction, a missing claim, or an unpaid provider bill. These are different mechanisms and may require different solutions.

    Save the plan’s explanation of benefits, denial letter, authorization number, portal messages, and provider communications. An explanation of benefits is not itself a bill. If the insurer has not issued a decision, ask for the status and the date on which it expects to respond.

    Describe effects without making unsupported medical claims

    Keep a factual log of canceled appointments, changed prescriptions, transportation expenses, additional calls, missed work, and out-of-pocket spending. If symptoms change, report them promptly to a clinician and record when you sought advice. Do not independently conclude that an insurer caused a particular injury; clinical causation requires medical evaluation.

    For example: ‘The imaging appointment scheduled for Tuesday was canceled after the facility said authorization was pending. I called the plan on Wednesday and received reference number X.’ That statement is more reliable than a broad allegation that the insurer refused all care.

    Coordinate with the treating practice

    Ask the practice which documents it submitted and whether a peer-to-peer discussion, corrected request, exception, or expedited review is available under the specific plan. A clinician can explain why waiting may be medically consequential. The patient should ask the practice how to handle symptoms or interruptions while the coverage question is being resolved.

    The administrative staff can document claim or authorization identifiers; the treating professional should supply clinical details. Keep these roles separate. If care is urgently needed, seek medical guidance rather than waiting for a routine billing response.

    Understand appeal routes

    For qualifying private plans, federal protections can allow internal appeals and independent external review of certain adverse decisions. The HealthCare.gov explanation of appeals describes written reasons and expedited review where appropriate. Plan type, urgency, and the notice determine which deadlines apply.

    If the dispute involves a Medicare Advantage plan, CMS describes the organization determination process. Do not use private-plan appeal deadlines for Medicare or Medicaid without checking the applicable rules.

    Prepare a concise impact statement

    State what was ordered, what the insurer said, what happened to the scheduled care, and what resolution you seek. Attach relevant documents in date order. A useful request might say: ‘Please identify the precise coverage criterion not met, the records reviewed, and the fastest available reconsideration process given the treating clinician’s concern about delay.’

    Keep the request factual and specific. Ask for written acknowledgment and a tracking number. If an insurer reverses its decision, confirm that the provider has received the updated authorization before assuming the appointment can proceed.

    Follow the consequences beyond the decision

    Once coverage is resolved, ask whether the missed appointment can be rescheduled, whether the provider needs a new order, and whether any interim charges remain. A favorable appeal does not automatically correct every billing entry. For more on documenting treatment impacts, maintain one timeline connecting clinical and financial events while keeping the underlying evidence available.

    Frequently asked questions

    Should I rely on a phone call alone? No. Preserve the written determination, reference numbers, and submission receipts.

    Does a complaint replace an appeal? Usually not. Follow the formal procedure and deadlines for the particular plan.

  • When Step Therapy Blocks a Medication, What Evidence Supports an Exception?

    A step-therapy denial does not necessarily end the effort to obtain a prescribed medication. Patients and clinicians can request the plan’s exception criteria, identify the precise reason for refusal, and submit medical evidence explaining why the preferred drug is unsuitable. The strongest request answers the insurer’s stated rule rather than simply repeating that the physician prescribed the treatment.

    First, identify what the plan actually denied

    Step therapy generally requires a patient to try a preferred treatment before the plan covers another option. But a pharmacy rejection, an incomplete prior authorization, a formulary exclusion, and a formal denial can look similar from the counter. Ask for the exact coverage determination, the plan provision involved, the drug and dose requested, and written instructions for exceptions and appeals. Confirm whether the request was sent to the correct pharmacy-benefit or medical-benefit administrator. A physician’s office should record the transaction identifier and the person or portal that supplied the denial reason.

    Build a clinical explanation tied to the rule

    A persuasive exception request identifies the prescribed drug, the diagnosis, the treatment objective, and the patient-specific reason the required alternative may not work. Useful records can include dates and outcomes of earlier therapies, adverse reactions, contraindications, relevant laboratory results, documented drug interactions, and an explanation of the risks of interruption. The clinician should distinguish a documented adverse effect from a concern that has not yet occurred. If a preferred treatment was never tried, explain why the clinician believes it is inappropriate instead of implying a trial happened.

    Separate urgency from ordinary review

    When delay could materially threaten health, ask the treating clinician whether an expedited review is medically justified. Do not assume every inconvenience qualifies. Ask the plan what evidence establishes urgency and what timeline applies to this particular coverage and request. A patient should discuss interim treatment options directly with the treating professional rather than changing or stopping medication based on a billing representative’s suggestion. Keep the appointment or treatment timeline separate from the administrative timeline.

    Use the appeal process without losing the record

    For plans governed by federal consumer appeal protections, HealthCare.gov explains internal appeals and independent external review. Medicare Part D, Medicaid, employer plans, and other coverage arrangements can have different procedures. Verify the controlling process and deadline in the denial notice. Submit the exception request through the prescribed channel, retain the confirmation, and ask for a written decision. If the insurer requests additional material, document precisely what was requested, who will send it, and the receipt date.

    What the patient and practice should track

    Maintain one chronological file: prescription date, pharmacy response, prior authorization request, clinical documentation, exception request, insurer acknowledgments, decision notices, and any missed or changed treatment. Patients can record the practical impact of delay without asserting that every symptom was caused by the insurer. Practices should preserve copies of submitted documents rather than assuming portal uploads remain accessible. The distinction matters if an appeal, regulator complaint, or later review requires proof of what the payer actually received.

    Questions worth asking

    Can the insurer identify the specific preferred therapy and the exception standard in writing? Does the plan require a trial, a contraindication, or another clinical criterion? Is the appeal deadline running while an exception is reviewed? Can a clinician submit an urgent request? Who can confirm receipt of supporting records? A useful follow-up is: “Please identify the exact criterion not met and provide the procedure for a written exception decision.”

    Further reading and official guidance

    See our related guide: practical background and next steps. For applicable official guidance, consult the federal source on this topic. Rules and deadlines depend on the plan and circumstances.